Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Schmits

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Science (New York, N.Y.)|June 9, 1995
Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor betaH Suzuki, T M Kündig, C Furlonger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2008
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimensL Trümper, C Zwick, M Ziepert, et al.
The Journal of Experimental Medicine|April 1, 1996
LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumorR Schmits, T M Kündig, D M Baker, et al.
Cell|February 23, 1996
Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient miceR Amakawa, A Hakem, T M Kundig, et al.
Blood|October 6, 1997
CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicityR Schmits, J Filmus, N Gerwin, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Science (New York, N.Y.)|June 9, 1995
Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor betaH Suzuki, T M Kündig, C Furlonger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2008
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimensL Trümper, C Zwick, M Ziepert, et al.
The Journal of Experimental Medicine|April 1, 1996
LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumorR Schmits, T M Kündig, D M Baker, et al.
Cell|February 23, 1996
Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient miceR Amakawa, A Hakem, T M Kundig, et al.
Blood|October 6, 1997
CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicityR Schmits, J Filmus, N Gerwin, et al.
Pageof 4